Stockreport

Biomea Fusion: Surging On Data, Sinking On Funding - I'm On The Sidelines [Seeking Alpha]

Biomea Fusion, Inc.  (BMEA) 
PDF BMEA's icovamenib showed durable HbA1c reductions in severe insulin-deficient and GLP-1 non-responder subgroups, but broader efficacy remains unproven in larger populat [Read more]